News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Debra Patt on the Importance of Policy Engagement in Oncology at ASCO 2025
Debra Patt/LinkedIn
Jun 1, 2025, 14:56

Debra Patt on the Importance of Policy Engagement in Oncology at ASCO 2025

Debra Patt, Chair of the AI Task Force and a Board Member for the American Society of Clinical Oncology (ASCO), shared a post on LinkedIn:

“You’re either at the table or on the menu.
-Al Capone (and Steve Paulson)
We are in an unprecedented time of policy change that could impact the patients we serve together. While often doctors don’t engage in public policy, it is so important to the nature of what we do. Like with our patients, with elected officials and their staff we are educators and guides to better solutions.
In my 20 years of clinical practice, I have never met an elected official or their staff that wanted cancer patients to have poor outcomes, diminished access, to suffer, or to have challenges navigating the healthcare landscape. And yet, frequently policy makers have limited understanding of the natural consequences of policy on these issues. Healthcare is in fact quite complicated. One forum for engagement is in the American Society of Clinical Oncology (ASCO) communities of practice.
Come and join us today. I will be speaking with Blase Polite, Jasmine Kamboj, Laurie Matt-Amaral, Brian Persing, Narjust Florez, Jonathan Ticku, Hesham ElGhazaly, Josh Pritchett, Martin Palmeri, Noha Soror, Nazli Dizman. Appreciate the advocacy in the cancer community – Community Oncology Alliance, Jeff Mortier, The US Oncology Network.”

More posts featuring Debra Patt on OncoDaily.

Al Capone American Society of Clinical Oncology ASCO ASCO 2025 Blase Polite Brian Persing cancer Community Oncology Alliance Debra Patt Hesham ElGhazaly Jasmine Kamboj Jeff Mortier Jonathan Ticku Josh Pritchett Laurie Matt-Amaral Martin Palmeri Narjust Florez Nazli Dizman Noha Soror OncoDaily Oncology Steve Paulson The US Oncology Network
Special Coverage
Oncolibrary
Jun 3, 2025, 00:40
THE LEAP trial at ASCO 2025 : Lenvatinib+pembrolizumab and chemotherapy vs.chemotherapy in a/mGEA
Oncolibrary
Jun 3, 2025, 00:22
Trial Updates at ASCO 2025: Neoadjuvant Pembrolizumab, Dabrafenib, and Trametinib in BRAF V600E-Mutated ATC
Blog
Jun 2, 2025, 18:21
Richard Lee: SIO Team Presented Real-World Implementation of ASCO-SIO Guidelines at ASCO25
Blog
Jun 2, 2025, 18:13
Chris Poulios: ASCO25 Sessions Include Patients' Perspective Along With Clinical and Laboratory-Focused Talks
Blog
Jun 2, 2025, 18:07
Sebastian Szmit: Right Ventricle in Patients With Cancer
Blog
Jun 2, 2025, 18:00
Shabnam Gujadhur: Day 2 at ASCO - Innovation, Insights, and Inspiration
Blog
Jun 2, 2025, 17:43
Gilberto Lopes Highlights Key Insights from Lung Oral Session at ASCO25
Blog
Jun 2, 2025, 17:33
Shivani Modi: Honored to Present Our Poster on Quantifying Financial Toxicity in Oncology at ASCO25
Blog
Jun 2, 2025, 17:18
Narjust Florez: Couldn’t Ask for a Better Partner as New IASLC Board Member
Blog
Jun 2, 2025, 17:06
Yüksel Ürün Highlights ML-integrated Biomarker Insights from CheckMate 9ER
Oncolibrary
Jun 2, 2025, 15:48
JAVELIN Bladder Medley Results: Avelumab + SG vs Avelumab in 1L Maintenance of Advanced UC
Blog
Jun 2, 2025, 15:40
Key Insights by Martin Zapata Laguado from ASCO25